您即将离开沛嘉医疗中文官网。
您刚才点击了进入另一网站的链接。如果继续,您可能会进入由第三方运行的网站。 我们不负责对非沛嘉医疗中文官网上的内容进行审核与管控,亦不会对您在非沛嘉医疗中文网上的任何商业交易或事物承担任何责任。您使用其他网站时,必须遵循该网站的使用条款及隐私声明。 其他网站上的部分产品和信息可能并未在您所在地区或国家获得批准。
取消
继续
Company News
Company News Brief News on Innovation
THE PROJECT OF PEIJIA MEDICAL HAS BEEN SELECTED FOR THE NATIONAL KEY R&D PROGRAM OF THE 14TH FIVE-YEAR PLAN
2025-01-08 10:51:15

The Ministry of Science and Technologyrecently unveiled the list of key projectsunder the "Diagnostic and TherapeuticEquipment and Biomedical Materials"category of the National Key R&DProgram for the 14th Five-Year Plan.Among these, the "New Materials andDevices for Minimally InvasiveInterventional Valves" project, led byPeijia Medical, has successfully beenincluded in the key R&D program.

1736477750162726.png

This project marks a significantinnovative achievement in the fieldof structural heart disease. It aimsto tackle the treatment challengesof severe cardiac conditions, suchas aortic valve stenosis andregurgitation, through advancedmedical technologies. Byproviding patients with safer, moreeffective, and durable treatmentoptions, the project seeks topropel the development of theheart valve disease treatmentsector.


Top